CIM Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $254K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $222K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $283K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $243K | Hold |
|
|||||
|
2020
Q3 | $233K | Buy |
|
|||||
|
2020
Q2 | $270K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $209K | Sell |
|
|||||
|
2019
Q3 | $355K | Hold |
|
|||||
|
2019
Q2 | $407K | Sell |
|
|||||
|
2019
Q1 | $457K | Buy |
|
|||||
|
2018
Q4 | $289K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $354K | Sell |
|
|||||
|
2017
Q2 | $632K | Sell |
|
|||||
|
2017
Q1 | $568K | Hold |
|
|||||
|
2016
Q4 | $545K | Hold |
|
|||||
|
2016
Q3 | $548K | Buy |
|
|||||
|
2016
Q2 | $615K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $331K | Hold |
|
|||||
|
2015
Q3 | $261K | Buy |
|
|||||
|
2015
Q2 | $271K | Sell |
|
|||||
|
2015
Q1 | $415K | Hold |
|
|||||
|
2014
Q4 | $286K | Buy |
|
|||||
|
2014
Q3 | $218K | Buy |
|